Investigational new drugs and ethical review: the adequacy of clinical research phases

Authors

  • José Roberto Goldim HCPA/GPPG

DOI:

https://doi.org/10.22491/2357-9730.2073

Keywords:

Pesquisa farmacológica, comitês de ética em pesquisa

Abstract

One of the most important warranties against abusive research procedures is the previous review by a Research Ethics Committee. New drugs research demands special attention in their evaluation, especially by the different phases that are involved in drug research. A comprehensive approach of characteristics, limits and aims of every research Project is fundamental to the evaluation

Downloads

Download data is not yet available.

Author Biography

José Roberto Goldim, HCPA/GPPG

Biólogo, Mestre em Educação, Doutor em Medicina: Clínica Médica, Professor de Bioética na UFRGS e na PUCRS, Pesquisador Responsável pelo Laboratório de Pesquisa em Bioética e Ética na Ciência do HCPA.

Published

2007-07-12

How to Cite

1.
Goldim JR. Investigational new drugs and ethical review: the adequacy of clinical research phases. Clin Biomed Res [Internet]. 2007 Jul. 12 [cited 2025 Aug. 29];27(1). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/2073

Issue

Section

Bioethics

Most read articles by the same author(s)

1 2 3 > >> 

Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 > >> 

You may also start an advanced similarity search for this article.